| 5 | 1/1 | 返回列表 |
| 查看: 785 | 回復(fù): 4 | ||
| 當(dāng)前只顯示滿足指定條件的回帖,點(diǎn)擊這里查看本話題的所有回帖 | ||
xiaomao225新蟲 (正式寫手)
|
[求助]
第一句怎么翻譯 已有2人參與
|
|
|
這句話怎么翻譯?只翻譯這句即可。TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche. 不用翻譯Abstract。 Abstract The aim of this study was to investigate the inhibitory effect of TSU68 [(Z)-5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid; SU6668], an inhibitor of vascular endothelial growth factor receptor 2, platelet-derived growth factor receptor beta, and fibroblast growth factor receptor 1 (FGFR1), on colon cancer liver metastasis, and to test the hypothesis that TSU68 modulates the microenvironment in the liver before the formation of metastasis. First, we implanted the highly metastatic human colon cancer TK-4 orthotopically into the cecal walls of nude mice, followed by twice-daily administration of TSU68 (400 mg/kg/d) or vehicle. Five weeks of treatment with TSU68 significantly inhibited liver metastasis compared with the control group (P<0.001). Next, we analyzed the gene expression profile in premetastatic liver using microarrays. Microarray and quantitative reverse transcription-PCR analysis showed that mRNA levels for the chemokine CXCL1 were significantly increased in tumor-bearing mice compared with non-tumor-bearing mice. Moreover, CXCL1 expression was significantly decreased by TSU68 treatment. CXCR2 expression was detected predominantly on tumor cells in orthotopic tumors compared with ectopic tumors. The number of migrating neutrophils in premetastatic liver was significantly decreased in the TSU68-treated group (P<0.001). The amount of interleukin-12 (IL-12) p40 in the portal vein was significantly decreased by TSU68 (P=0.02). Blockade of both CXCR2 and IL-12 p40 with a neutralizing antibody significantly inhibited liver metastasis. These results suggest that the CXCL1/CXCR2 axis is important in cancer metastasis and that TSU68 may modulate the premetastatic niche in the target organ through suppression of the inflammatory response, which might be an alternative mechanism used by antiangiogenic agents. |
銅蟲 (著名寫手)
新蟲 (正式寫手)
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 化學(xué)工程085602 305分求調(diào)劑 +25 | RichLi_ 2026-03-25 | 25/1250 |
|
|---|---|---|---|---|
|
[考研] 285求調(diào)劑 +5 | AZMK 2026-03-29 | 8/400 |
|
|
[考研] 一志愿南航 335分 | 0856 | GPA 4.07 | 有科研經(jīng)歷 +8 | cccchenso 2026-03-29 | 8/400 |
|
|
[考研] 一志愿華東師范大學(xué)有機(jī)化學(xué)專業(yè),初試351分,復(fù)試被刷求調(diào)劑! +5 | 真名有冰 2026-03-29 | 6/300 |
|
|
[考研] 307求調(diào)劑 +9 | 超級(jí)伊昂大王 2026-03-24 | 10/500 |
|
|
[考研] 08工科求調(diào)劑286 +3 | tgs_001 2026-03-28 | 3/150 |
|
|
[考研] 環(huán)境工程 085701,267求調(diào)劑 +6 | minht 2026-03-29 | 6/300 |
|
|
[考研] 315求調(diào)劑 +4 | akie... 2026-03-28 | 5/250 |
|
|
[考研] 312,生物學(xué)求調(diào)劑 +3 | 小譯同學(xué)abc 2026-03-28 | 3/150 |
|
|
[考研] 299求調(diào)劑 +7 | 嗯嗯嗯嗯2 2026-03-27 | 7/350 |
|
|
[考研] 081200-314 +3 | LILIQQ 2026-03-27 | 4/200 |
|
|
[考研] 材料求調(diào)劑 一志愿哈工大總分298分,前三科223分 +5 | dongfang59 2026-03-27 | 5/250 |
|
|
[考研] 085701環(huán)境工程求調(diào)劑 +9 | 多久上課 2026-03-27 | 9/450 |
|
|
[考研] 272求調(diào)劑 +7 | 腳滑的守法公民 2026-03-27 | 7/350 |
|
|
[考研] 081200-11408-276學(xué)碩求調(diào)劑 +4 | 崔wj 2026-03-26 | 4/200 |
|
|
[考研] 351求調(diào)劑 +4 | 麥克阿磊 2026-03-24 | 4/200 |
|
|
[考研] 材料考研求調(diào)劑 +3 | Dendel 2026-03-23 | 6/300 |
|
|
[考研] 材料科學(xué)與工程 317求調(diào)劑 +4 | JKSOIID 2026-03-26 | 4/200 |
|
|
[考研] 一志愿 南京郵電大學(xué) 288分 材料考研 求調(diào)劑 +3 | jl0720 2026-03-26 | 3/150 |
|
|
[考研] 0854AI CV方向招收調(diào)劑 +4 | 章小魚567 2026-03-23 | 4/200 |
|